Objectives: Dual sofosbuvir/daclatasvir (SOF/DCV) therapy is currently recommended by
the European Association for Study of Liver (EASL) as an option for the treatment of chronic …

Only a few treatments are approved for coronavirus disease‐2019 (COVID‐19) infections,
with continuous debate about their clinical impact. Repurposing antiviral treatments might …

Background: Lactuca sativa (garden lettuce) is a popular salad herb. It has been in use in folk
medicine since ancient times as both an appetite stimulant and as an aid to sleep. L. sativa …

Objective We aimed to investigate the effect of topical application of a Copper indomethacin
(Cu-Indo) gel preparation on monosodium iodoacetate (MIA) induced arthritis of the knee …

Purpose – the purpose of this paper is to investigate the impact of a number of Islamic
values on interpersonal relationship conflict management in Egyptian Pharmaceutical …

Background & Aims Although treatment of hepatitis C virus (HCV) and HCV-genotype-4 (GT4)
has become very effective, it remains very expensive, and affordable options are needed, …

Background Mild cognitive impairment encompasses the clinical continuum between
physiologic age-related cognitive changes and dementia. A variety of medications, including …

COVID-19 is a pandemic disease caused by SARS-CoV-2, which is an RNA virus similar to
the hepatitis C virus (HCV) in the replication process. Sofosbuvir/ledipasvir is an approved …

Mass production of low-cost, generic direct-acting antivirals (DAAs) will be required to achieve
targets of eliminating hepatitis C (HCV) by 2030. The pharmaceutical companies Gilead …

… Abbass Helmy Charity and Pharco shared in funding the study, they contributed to study
design, … We thank Abbass Helmy Charity establishment and Pharco for their sincere help and …